Medical Aid Dispute: South African Complaint Routes

Key takeaways

• A South African medical aid dispute should usually begin with the medical scheme’s own complaints and dispute process. If that process does not resolve a matter within the Council for Medical Schemes’ jurisdiction, an aggrieved person can submit a written complaint to the Registrar under section 47 of the Medical Schemes Act. A decision can then follow different statutory appeal routes under sections 48, 49 and 50. High Court judicial review is a later, distinct remedy and generally requires the relevant internal remedies to be exhausted first.
• The right route depends on the product, decision-maker and outcome sought. A rejected hospital claim, short payment, prescribed minimum benefit dispute, designated-service-provider penalty, membership termination and broker complaint may require different evidence. A complaint about negligent treatment belongs to a healthcare or civil-liability route, not to the Council merely because a medical scheme paid for the treatment.
• For clinically urgent funding, mark the matter urgent and attach current clinical evidence when using the scheme and Council processes. If delay creates an immediate threat to life, health or access to necessary treatment, obtain current clinical help and urgent legal advice rather than waiting for an ordinary complaint timetable.

Map the route before sending the complaint

Do not treat the words “appeal,” “review,” “reconsideration” and “complaint” as interchangeable. The document being challenged should identify who made the decision, the empowering section, the next body, filing format and deadline.

1. Confirm that the product and respondent fall within the CMS route

“Medical aid” is the common expression, but the Medical Schemes Act regulates registered medical schemes and specified registered or accredited participants. The Council’s current complaints page says its mandate covers complaints concerning medical schemes and people or entities registered or accredited under the Act, including administrators, managed-care organisations and healthcare brokers within the statutory scope. It also describes a route for certain exempted health-insurance providers.

Start with the membership certificate, scheme name and option. Distinguish:

• the registered medical scheme, which carries the scheme obligations;
• the administrator handling communications or claims;
• a managed-care organisation making or supporting clinical-funding decisions;
• the broker who advised on or facilitated membership;
• the healthcare provider who supplied treatment; and
• an insurer selling a separate insurance product.

Branding can make these roles look like one business when the legal entities and mandates differ. Record the full entity name on every decision, not only the app or product logo.

The CMS does not investigate every healthcare disagreement. A dispute about a doctor’s professional conduct may belong to the relevant professional council. A complaint about standards at a health establishment may belong to the facility or Health Ombud. A damages claim for negligent treatment is a separate civil assessment. The article on hospital complaints owns that care-quality comparison; this guide is limited to medical-scheme decisions and their escalation.

2. Identify the exact decision and remedy

Do not complain only that “the medical aid refused to pay.” Break the problem into a reviewable decision.

Common categories include:

• prior authorisation refused, limited or withdrawn;
• a claim rejected or paid below the invoiced amount;
• a condition or treatment not recognised as a prescribed minimum benefit;
• a designated service provider, network, formulary or protocol applied incorrectly;
• a co-payment or deductible imposed despite alleged involuntary non-DSP use;
• chronic medicine registration refused or removed;
• benefits debited from a savings account or ordinary benefit instead of the claimed risk benefit;
• waiting period, late-joiner penalty or membership eligibility dispute;
• suspension or termination of membership;
• contribution, dependant or rule-interpretation dispute;
• broker, administrator or managed-care conduct within the Act; or
• failure to give intelligible reasons or apply the registered rules.

State the remedy in terms the decision-maker can implement: approve a specified authorisation, reprocess identified claim lines, recognise a stated PMB entitlement, remove a particular co-payment, restore membership, correct a contribution record, provide reasons, or reconsider the decision under the correct rule.

The CMS’s current page states that the Registrar cannot award punitive costs or compensation for delay, pain and suffering; order interest; discipline employees; order payment of expenses lawfully excluded from benefits; or order a full contribution refund unless the registered rules provide for it. A person seeking those outcomes may need separate legal advice even while the benefit dispute follows the statutory route.

3. Get the governing rules and reasons before arguing the merits

Section 32 of the Medical Schemes Act makes a registered scheme’s rules binding on the scheme, its members, officers and people claiming under the rules. Section 29 requires scheme rules to provide for complaints and disputes between the scheme and members or former members, including provision for an independent person to decide disputes.

Request the version that applied on the treatment, claim, authorisation or membership-decision date. A current brochure may not prove an earlier entitlement. Collect:

1. the registered scheme rules and relevant annexures;
2. the benefit-option schedule for the applicable year;
3. the pre-authorisation, managed-care, formulary and network terms relied on;
4. the full rejection or short-payment code and plain-language reasons;
5. the rule, protocol or clinical criterion cited in the decision;
6. the identity and role of the decision-maker;
7. the internal complaint and appeal procedure;
8. the date the decision was communicated; and
9. the next route and deadline stated in the outcome.

If a telephone agent gave the reason, ask for it in writing. Preserve the call date, reference number and the wording used, but do not treat a call-centre summary as the registered rule.

Use the consumer-rights complaint pack to index the decision, applicable terms, communications and proof of submission.

4. Build the clinical and financial evidence separately

A scheme cannot evaluate a clinical-funding dispute without enough clinical material, and a clinical opinion cannot reconcile an account without claim data. Build two linked files.

Clinical file

Include only material relevant to the disputed funding decision:

• treating practitioner’s diagnosis and report;
• ICD-10 and procedure codes as actually submitted;
• treatment plan, dosage, duration and clinical indication;
• test results or imaging reports relied on;
• referral and motivation letters;
• previous therapies, response and adverse effects where a protocol exception is sought;
• emergency presentation facts and timing;
• why a designated provider was unavailable, unreasonably delayed or not reasonably accessible, if alleged; and
• the practitioner’s answer to the scheme’s stated clinical reason.

Financial and decision file

Include:

• membership number, beneficiary and option;
• provider invoice and itemised account;
• claim statement, remittance advice and rejection codes;
• amounts invoiced, paid by the scheme and paid by the member;
• authorisation numbers and conditions;
• network or DSP correspondence;
• the scheme’s original decision and every internal outcome;
• proof of submission and receipt; and
• a calculation of the exact amount or authorisation still disputed.

Do not send unrelated medical history. If a representative complains for the beneficiary, include the signed consent or authority required by the receiving body. The CMS page specifically asks for consent where a third party submits the complaint.

5. Test a PMB argument against the regulations, not the label alone

Prescribed minimum benefits are defined benefits created under the Medical Schemes Act regulations. The CMS’s current PMB guidance describes three broad groups: emergency medical conditions, the conditions in the Diagnosis and Treatment Pairs, and the Chronic Disease List.

A diagnosis does not answer every funding question. Check:

• whether the condition falls within the current PMB definition;
• the diagnosis-and-treatment pair or chronic-disease entitlement relied on;
• whether the requested treatment is part of the prescribed diagnosis, treatment and care;
• the scheme’s registered DSP arrangements;
• any formulary or protocol and the exception process;
• whether the member used a non-DSP voluntarily or involuntarily; and
• whether the submitted codes and clinical records allow the scheme to identify the entitlement.

Regulation 8 requires PMB diagnosis, treatment and care to be paid in full, subject to its provisions. Scheme rules may require use of a designated service provider and may impose a co-payment for voluntary non-DSP use. Regulation 8 also identifies circumstances in which non-DSP use is deemed involuntary, including unavailability or unreasonable delay, an immediate treatment need that reasonably precluded use of the DSP, or no DSP within reasonable proximity to the beneficiary’s ordinary work or residence.

Do not reduce this to “PMBs are always paid at any provider’s rate” or “using a non-network provider always creates a co-payment.” The entitlement, registered rules, treatment, provider choice and facts must be matched to the regulation. The consumer complaint checklist can help turn those issues into a focused request and requested outcome.

6. Complete the scheme’s internal dispute process

The CMS’s current complaints procedure instructs prospective complainants to exhaust the scheme or regulated entity’s internal process first. The exact internal steps and timeframes depend on the registered rules and the decision.

Submit one structured internal complaint containing:

1. the member, beneficiary, scheme and option;
2. the decision, date and reference number;
3. the rule or statutory entitlement relied on;
4. the material facts in chronological order;
5. a response to each stated rejection reason;
6. a numbered list of attachments;
7. the precise remedy requested; and
8. a request for a written outcome stating reasons and further appeal rights.

Keep the original submission, portal confirmation, email headers and final internal decision. If the rules contain more than one internal level, identify whether every required level has been used. Do not submit a duplicate complaint through several channels without cross-referencing it; fragmented files can obscure the issue.

For a clinically urgent matter, write “clinically urgent” in the subject, identify the treatment decision and required date, and attach a current practitioner statement explaining the medical consequence of delay. Do not call a dispute urgent only because the amount is large.

7. Escalate a qualifying complaint to the Registrar

Section 47 of the Medical Schemes Act governs written complaints concerning matters provided for in the Act. The Council’s current process says a person aggrieved by conduct within its statutory mandate may complain after exhausting the internal process.

The CMS asks for:

• a completed complaint form with the facts and desired recourse;
• proof of prior escalation with the scheme or regulated entity;
• signed consent where a third party acts for the beneficiary;
• relevant clinical reports for a clinical dispute;
• account statements for unpaid or short-paid claims; and
• other supporting records.

Section 47 requires the complaint to be supplied to the party concerned and gives that party 30 days, or a longer period the Registrar may allow, to provide written comments. A fair file must therefore anticipate the scheme’s reason and answer it with evidence rather than rhetoric.

The CMS encourages submission as soon as internal resolution fails and currently says this should preferably be within three years. “Preferably” on an operational webpage should not be treated as a universal statutory prescription ruling. Separate deadlines may affect contractual, delictual, administrative-review or other court relief. Record them independently and obtain advice where financial loss or urgent treatment may justify another remedy.

The CMS publishes service targets, but those are not guaranteed decision dates. Its page says clinically urgent complaints are handled urgently. Keep treatment planning and clinical follow-up separate from assumptions about the complaint timetable.

8. Choose the correct statutory appeal

Chapter 10 of the Medical Schemes Act contains several appeal routes. Selecting one from a generic internet summary is unsafe; use the actual decision and current CMS forms.

Section 48: settlement of a complaint or dispute

A person aggrieved by a decision relating to settlement of a complaint or dispute may appeal to the Council. Section 48 requires an affidavit directed to the Council within three months after the decision. The Council may condone a late appeal on good cause. The decision under appeal is suspended pending the Council’s decision.

Section 49: another decision of the Registrar

Section 49 applies to a person aggrieved by a decision of the Registrar made under a power conferred or duty imposed by the Act, where that decision is not governed by section 48. The appeal is to the Council and must be lodged within 30 days after the decision. The operation of the decision is suspended pending the Council’s decision.

Section 50: appeal from the Council to the Appeal Board

A party aggrieved by a Council decision under section 48 or 49 may appeal to the Appeal Board. The notice must be delivered within 60 days after the Council’s decision and be supported by written arguments or an explanation of the grounds. A prescribed fee applies. The Appeal Board may confirm, set aside or vary the Council’s decision and has statutory powers to receive evidence and documents.

The CMS describes section 50 as the next appeal from the Appeal Committee to the Appeal Board. In Cotty v Registrar, the High Court treated it as the final step in the Act’s internal dispute-resolution process and held that a section 48 or 49 decision generally remains subject to the section 50 remedy before judicial review.

Create a deadline sheet showing the decision date, receipt date, empowering section, last filing date, format, fee, service requirements and proof of delivery. Do not assume that asking for reasons or negotiating with the scheme pauses an appeal period.

9. Understand what High Court review can and cannot do

Judicial review is not simply another opportunity to argue that the benefit should have been approved. Under the Promotion of Administrative Justice Act, a court reviews administrative action for grounds such as unlawfulness, procedural unfairness, relevant and irrelevant considerations, error of law or unreasonableness.

Section 7 of PAJA generally requires available internal remedies to be exhausted. A court can exempt a person from that requirement in exceptional circumstances where the interests of justice support exemption, but exemption should not be assumed. The Justice Department’s PAJA guidance states that review proceedings must ordinarily be brought without unreasonable delay and within 180 days after internal remedies are concluded, or, where none exist, after the person became aware or could reasonably have become aware of the decision and reasons.

In Swanepoel v Profmed Medical Scheme, the Constitutional Court dealt with litigation following a scheme termination, Registrar complaint, Council appeal, Appeal Board appeal and High Court PAJA review. The case illustrates the route and confirms that PAJA governs review of the Appeal Board’s administrative decision; it does not mean every benefit dispute should proceed to court.

A review record, grounds and remedy require specialist assessment. Depending on the case, a court may set aside a decision and remit it for reconsideration or grant other just and equitable relief. It does not automatically substitute a funding approval or award damages.

Urgent court relief may sometimes be considered before ordinary processes conclude, but urgency, jurisdiction, exhaustion, interim-relief requirements, undertakings and costs all require case-specific legal advice. A threatened treatment date alone does not guarantee an order.

10. Keep compensation and other claims separate

The CMS route resolves matters within the Medical Schemes Act. It does not automatically compensate a member for consequential loss, pain, distress, deterioration or a provider’s treatment. If loss is alleged, ask a lawyer to identify:

• the legal cause of action;
• the correct scheme, administrator, provider, broker or other defendant;
• whether internal remedies must first be completed;
• the decision or conduct said to be wrongful;
• factual and legal causation;
• documentary and expert evidence;
• prescription or review deadlines; and
• the relief a competent court can grant.

Do not describe an unpaid account as damages twice. Separate the benefit amount claimed under the rules from additional loss said to have resulted from the refusal or delay.

The lawyer consultation preparation guide can help structure this handover. The legal-services hub and Lexuno lawyer directory support provider discovery but do not determine CMS jurisdiction, preserve a deadline, prove a PMB entitlement or predict an outcome.

A dispute-file completion check

Before submitting or escalating, confirm that the file contains:

Identity and mandate

• registered scheme, option, member and beneficiary;
• correct respondent and its legal role;
• representative consent or authority; and
• secure handling of medical and identity information.

Decision and law

• written decision, date, reference and reasons;
• applicable registered rules and benefit schedule;
• statutory or regulatory provision relied on;
• PMB, DSP, formulary or protocol analysis where relevant; and
• exact remedy within the receiving body’s powers.

Evidence

• clinical motivation addressing the stated reason;
• claim, invoice, remittance and amount calculation;
• complete internal submissions and outcomes;
• numbered supporting documents; and
• proof of every submission and receipt.

Route and timing

• internal process completed or reason urgent intervention is sought;
• CMS jurisdiction confirmed;
• sections 47, 48, 49 and 50 distinguished;
• appeal and judicial-review dates recorded separately; and
• separate compensation, treatment or provider-conduct route identified where required.

Source and review note

This guide was checked against the Medical Schemes Act, the 2002 amendment to regulation 8, the Council for Medical Schemes’ current complaints and PMB guidance, the Promotion of Administrative Justice Act, Justice Department review guidance, Genesis Medical Scheme v Chairperson of the Appeal Board, Cotty v Registrar and Swanepoel v Profmed Medical Scheme.

Operational forms, scheme rules, benefit schedules, protocols, regulated entities, fees and deadlines must be checked again when a dispute is filed. This is general legal information, not medical or legal advice. It does not establish benefit entitlement, urgency, CMS jurisdiction, appeal validity, review grounds, damages or a likely result.

FAQs

Related Lexuno paths